Hefny Pharma Group

Bilifalk 500 mg

Bilifalk 500 mg

ursodeoxycholic acid 500 mg tablets
The daily dose depends on body weight, and ranges from 3 to 6 tablets (12-16 mg UDCA per kg of body weight). For 3 months
Billifalk is indicated in the treatment of primary biliary cirrhosis (PBC) & for the dissolution of radiolucent gallstones in patients with a functioning gall bladder. Also indicated for hepatobiliary disorders associated with cystic fibrosis in children aged 6 to 18 years